Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1987 Jun;61(6):2017–2023. doi: 10.1128/jvi.61.6.2017-2023.1987

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

B Wahren, L Morfeldt-Månsson, G Biberfeld, L Moberg, A Sönnerborg, P Ljungman, A Werner, R Kurth, R Gallo, D Bolognesi
PMCID: PMC254211  PMID: 3033328

Abstract

The human immunodeficiency virus (HIV)-specific lymphocyte proliferation response was determined for 40 persons at different stages of HIV infection. The specific response to purified HIV virion antigens from strain HTLV-IIIB was poor, occurred in only 9 of the 40 subjects, was not improved with the addition of interleukin-2, and was more frequent in symptom-free individuals (46%) than in patients with lymphadenopathy syndrome (10%). Reactivity to subcomponent p24 was better than that to whole HIV; reactivity was present in five of six infected persons and increased with the addition of exogenous interleukin-2. Reactivities to subcomponents (g)p41 and gp120 were also measured. This is the first evidence of a specific cell-mediated immune response to HIV antigen in HIV-infected persons. Monkeys immunized with purified HIV or with purified p24 displayed cellular immunoreactivity both to whole HIV and to subcomponents. In contrast to the poor reactivity to HIV antigen, the lymphocytes of the patients had good specific cell proliferation responses to cytomegalovirus and herpes simplex virus challenge and a normal response to the addition of phytohemagglutinin. The results suggest a functional defect in peripheral lymphocytes of some HIV-infected individuals on the basis of their response to whole HIV antigen and a better response to gag protein.

Full text

PDF
2017

Images in this article

2018Image
on p.2018

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  2. Borysiewicz L. K., Morris S., Page J. D., Sissons J. G. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur J Immunol. 1983 Oct;13(10):804–809. doi: 10.1002/eji.1830131005. [DOI] [PubMed] [Google Scholar]
  3. Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 1985 Oct 25;230(4724):453–455. doi: 10.1126/science.2996136. [DOI] [PubMed] [Google Scholar]
  4. Dalgleish A. G., Beverley P. C., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984 Dec 20;312(5996):763–767. doi: 10.1038/312763a0. [DOI] [PubMed] [Google Scholar]
  5. Dorsett B., Cronin W., Chuma V., Ioachim H. L. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome. Am J Med. 1985 Apr;78(4):621–626. doi: 10.1016/0002-9343(85)90405-x. [DOI] [PubMed] [Google Scholar]
  6. Enk C., Gerstoft J., Møller S., Remvig L. Interleukin 1 activity in the acquired immunodeficiency syndrome. Scand J Immunol. 1986 Apr;23(4):491–497. doi: 10.1111/j.1365-3083.1986.tb03081.x. [DOI] [PubMed] [Google Scholar]
  7. Epstein J. S., Frederick W. R., Rook A. H., Jackson L., Manischewitz J. F., Mayner R. E., Masur H., Enterline J. C., Djeu J. Y., Quinnan G. V., Jr Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis. 1985 Oct;152(4):727–733. doi: 10.1093/infdis/152.4.727. [DOI] [PubMed] [Google Scholar]
  8. Fossum C., Bergman R., Morein B. Suppressor activity of bovine Fc gamma positive cells during a persistent infection with Mycobacterium avium. Res Vet Sci. 1985 May;38(3):270–274. [PubMed] [Google Scholar]
  9. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  10. Ghrayeb J., Kato I., McKinney S., Huang J. J., Chanda P. K., Ho D. D., Sarangadharan M. G., Chang T. W., Chang N. T. Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera. DNA. 1986 Apr;5(2):93–99. doi: 10.1089/dna.1986.5.93. [DOI] [PubMed] [Google Scholar]
  11. Gilljam G., Sundqvist V. A., Linde A., Pihlstedt P., Eklund A. E., Wahren B. Sensitive analytic ELISAs for subclass herpes virus IgG. J Virol Methods. 1985 Mar;10(3):203–214. doi: 10.1016/0166-0934(85)90061-8. [DOI] [PubMed] [Google Scholar]
  12. Hersh E. M., Gutterman J. U., Spector S., Friedman H., Greenberg S. B., Reuben J. M., LaPushin R., Matza M., Mansell P. W. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome. Cancer Res. 1985 Jan;45(1):406–410. [PubMed] [Google Scholar]
  13. Kiprov D. D., Anderson R. E., Morand P. R., Simpson D. M., Chermann J. C., Levy J. A., Ross A. R. Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS. N Engl J Med. 1985 Jun 6;312(23):1517–1517. doi: 10.1056/NEJM198506063122312. [DOI] [PubMed] [Google Scholar]
  14. Klatzmann D., Barré-Sinoussi F., Nugeyre M. T., Danquet C., Vilmer E., Griscelli C., Brun-Veziret F., Rouzioux C., Gluckman J. C., Chermann J. C. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 1984 Jul 6;225(4657):59–63. doi: 10.1126/science.6328660. [DOI] [PubMed] [Google Scholar]
  15. Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985 Jul 11;313(2):79–84. doi: 10.1056/NEJM198507113130204. [DOI] [PubMed] [Google Scholar]
  16. Levandowski R. A., Ou D. W., Jackson G. G. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis. 1986 Apr;153(4):743–748. doi: 10.1093/infdis/153.4.743. [DOI] [PubMed] [Google Scholar]
  17. Ljungman P., Lönnqvist B., Gahrton G., Ringdén O., Wahren B. Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation. Blood. 1986 Jul;68(1):108–112. [PubMed] [Google Scholar]
  18. Ljungman P., Lönnqvist B., Wahren B., Ringdén O., Gahrton G. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up. Transplantation. 1985 Nov;40(5):515–520. doi: 10.1097/00007890-198511000-00009. [DOI] [PubMed] [Google Scholar]
  19. Ljungman P., Wahren B., Sundqvist V. A. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase. J Virol Methods. 1985 Dec;12(3-4):199–208. doi: 10.1016/0166-0934(85)90130-2. [DOI] [PubMed] [Google Scholar]
  20. McMichael A. J., Michie C. A., Gotch F. M., Smith G. L., Moss B. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol. 1986 Apr;67(Pt 4):719–726. doi: 10.1099/0022-1317-67-4-719. [DOI] [PubMed] [Google Scholar]
  21. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  22. Quinnan G. V., Jr, Kirmani N., Rook A. H., Manischewitz J. F., Jackson L., Moreschi G., Santos G. W., Saral R., Burns W. H. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med. 1982 Jul 1;307(1):7–13. doi: 10.1056/NEJM198207013070102. [DOI] [PubMed] [Google Scholar]
  23. Rand K. H., Rasmussen L. E., Pollard R. B., Arvin A., Merigan T. C. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977 Jun 16;296(24):1372–1377. doi: 10.1056/NEJM197706162962402. [DOI] [PubMed] [Google Scholar]
  24. Reuben J. M., Hersh E. M., Mansell P. W., Newell G., Rios A., Rossen R., Goldstein A. L., McClure J. E. Immunological characterization of homosexual males. Cancer Res. 1983 Feb;43(2):897–904. [PubMed] [Google Scholar]
  25. Rook A. H., Masur H., Lane H. C., Frederick W., Kasahara T., Macher A. M., Djeu J. Y., Manischewitz J. F., Jackson L., Fauci A. S. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest. 1983 Jul;72(1):398–403. doi: 10.1172/JCI110981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sandstrom E. G., Kaplan J. C., Byington R. E., Hirsch M. S. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate. Lancet. 1985 Jun 29;1(8444):1480–1482. doi: 10.1016/s0140-6736(85)92255-x. [DOI] [PubMed] [Google Scholar]
  27. Shearer G. M., Payne S. M., Joseph L. J., Biddison W. E. Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome. J Clin Invest. 1984 Aug;74(2):496–506. doi: 10.1172/JCI111447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sheridan J. F., Aurelian L., Donnenberg A. D., Quinn T. C. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses. J Clin Immunol. 1984 Jul;4(4):304–311. doi: 10.1007/BF00915298. [DOI] [PubMed] [Google Scholar]
  29. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. 1986 Jul 31-Aug 6Nature. 322(6078):470–474. doi: 10.1038/322470a0. [DOI] [PubMed] [Google Scholar]
  30. Sundqvist V. A., Linde A., Kurth R., Werner A., Helm E. B., Popovic M., Gallo R. C., Wahren B. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis. 1986 May;153(5):970–973. doi: 10.1093/infdis/153.5.970. [DOI] [PubMed] [Google Scholar]
  31. Sundqvist V. A., Wahren B. An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods. 1981 Apr;2(5):301–312. doi: 10.1016/0166-0934(81)90029-x. [DOI] [PubMed] [Google Scholar]
  32. Tevethia S. S., Flyer D. C., Tjian R. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). Virology. 1980 Nov;107(1):13–23. doi: 10.1016/0042-6822(80)90268-8. [DOI] [PubMed] [Google Scholar]
  33. Townsend A. R., Skehel J. J., Taylor P. M., Palese P. Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone. Virology. 1984 Mar;133(2):456–459. doi: 10.1016/0042-6822(84)90413-6. [DOI] [PubMed] [Google Scholar]
  34. Wahren B., Ljungman P., Paulin T., Ringdén O. Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro. J Virol. 1986 Jun;58(3):909–913. doi: 10.1128/jvi.58.3.909-913.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wahren B., Morfeldt-Månsson L., Biberfeld G., Moberg L., Ljungman P., Nordlund S., Bredberg-Rådén U., Werner A., Löwer J., Kurth R. Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. N Engl J Med. 1986 Aug 7;315(6):393–394. [PubMed] [Google Scholar]
  36. Wahren B., Nordlund S., Akesson A., Sundqvist V. A., Morein B. Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus. Med Microbiol Immunol. 1987;176(1):13–19. doi: 10.1007/BF00189404. [DOI] [PubMed] [Google Scholar]
  37. Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986 May 9;232(4751):727–732. doi: 10.1126/science.3008337. [DOI] [PubMed] [Google Scholar]
  38. Wallace J. I., Coral F. S., Rimm I. R., Lane H., Levine H., Reinherz E. L., Schlossman S. F., Sonnabend J. T-cell ratios in homosexuals. Lancet. 1982 Apr 17;1(8277):908–908. doi: 10.1016/s0140-6736(82)92177-8. [DOI] [PubMed] [Google Scholar]
  39. Yewdell J. W., Bennink J. R., Mackett M., Lefrancois L., Lyles D. S., Moss B. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. J Exp Med. 1986 Jun 1;163(6):1529–1538. doi: 10.1084/jem.163.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yewdell J. W., Bennink J. R., Smith G. L., Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785–1789. doi: 10.1073/pnas.82.6.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES